Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07312773
PHASE1
A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
To evaluate the pharmacokinetic interactions of AD-231A, AD-231B, and AD-231C in healthy adult volunteers.
Official title: A Two-arm, Open-label, Single-sequence, Multiple-dose Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
55
Start Date
2026-01-23
Completion Date
2026-02-22
Last Updated
2025-12-31
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Treatment A(AD-231A)
AD-231A Oral Tablet
DRUG
Treatment B(AD-231B+AD-231C)
AD-231B+AD-231C Oral Tablet
DRUG
Treatment C(AD-231A+AD-231B+AD-231C)
AD-231A+AD-231B+AD-231C Oral Tablet
Locations (1)
H+ Yangji Hospital
Seoul, South Korea